Stenocare AS
Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD oil products. The company was incorporated in 2017 and is based in Randers, Denmark.
Stenocare AS (STENO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.316x
Based on the latest financial reports, Stenocare AS (STENO) has a cash flow conversion efficiency ratio of -0.316x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr-3.02 Million) by net assets (Dkr9.55 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Stenocare AS - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Stenocare AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Stenocare AS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Stenocare AS ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Semilux International Ltd. Ordinary Shares
NASDAQ:SELX
|
-0.064x |
|
URU METALS LTD
F:NVRA
|
N/A |
|
Dynaciate Group Bhd
KLSE:5178
|
0.016x |
|
paragon GmbH & Co. KGaA
F:PGN
|
0.013x |
|
VIOL Co. Ltd
KQ:335890
|
0.042x |
|
Acrux Limited
PINK:ARUXF
|
-4.086x |
|
Marvel Biosciences Corp.
PINK:MBCOF
|
0.049x |
|
Neurobo Pharmaceuticals Inc
NASDAQ:NRBO
|
-0.431x |
Annual Cash Flow Conversion Efficiency for Stenocare AS (2018–2025)
The table below shows the annual cash flow conversion efficiency of Stenocare AS from 2018 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Dkr9.55 Million | Dkr-7.21 Million | -0.755x | -136.74% |
| 2024-12-31 | Dkr-3.47 Million | Dkr-7.14 Million | 2.056x | +628.68% |
| 2023-12-31 | Dkr25.82 Million | Dkr-10.04 Million | -0.389x | +37.55% |
| 2022-12-31 | Dkr24.14 Million | Dkr-15.03 Million | -0.623x | -87.79% |
| 2021-12-31 | Dkr40.24 Million | Dkr-13.34 Million | -0.332x | -37.22% |
| 2020-12-31 | Dkr52.57 Million | Dkr-12.70 Million | -0.242x | -27.96% |
| 2019-12-31 | Dkr13.47 Million | Dkr-2.54 Million | -0.189x | +30.65% |
| 2018-12-31 | Dkr20.47 Million | Dkr-5.57 Million | -0.272x | -- |